WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Cheuk Hei Ho
Patent Agent
Patents and Innovations
Boulder
cheiho@wsgr.com

D617-598-7874

Download vCard
Open PDF

Dr. Cheuk Hei Ho is a patent agent in the Boulder office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice. Cheuk Hei has over ten years of experience in life science research. His diverse scientific expertise includes biotechnology, chemical genetics, functional genomics, gene editing, microbiology, molecular and cell biology, neurobiology, and RNA biology.

Cheuk Hei conducted his postdoctoral research in the Skirball Institute of Biomolecular Medicine at New York University Langone Medical Center, focusing on the development of the nervous system. He studied how the proper scale of a neuron and its target tissue is regulated during development in the fruit fly.

Cheuk Hei earned his Ph.D. degree in Molecular Genetics from the University of Toronto. His research focused on developing functional genomics tools to study the mechanism-of-action of bioactive chemical compounds in the budding yeast. He also constructed the first genome-wide dosage-suppression genetic-interaction network.

Before joining the firm, Cheuk Hei interned in the New York University Office of Industrial Liaison/Technology Transfer. He conducted patentability assessments and strategized responses to Office actions for inventions that originated in New York University.

Experience

Dr. Cheuk Hei Ho is a patent agent in the Boulder office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice. Cheuk Hei has over ten years of experience in life science research. His diverse scientific expertise includes biotechnology, chemical genetics, functional genomics, gene editing, microbiology, molecular and cell biology, neurobiology, and RNA biology.

Cheuk Hei conducted his postdoctoral research in the Skirball Institute of Biomolecular Medicine at New York University Langone Medical Center, focusing on the development of the nervous system. He studied how the proper scale of a neuron and its target tissue is regulated during development in the fruit fly.

Cheuk Hei earned his Ph.D. degree in Molecular Genetics from the University of Toronto. His research focused on developing functional genomics tools to study the mechanism-of-action of bioactive chemical compounds in the budding yeast. He also constructed the first genome-wide dosage-suppression genetic-interaction network.

Before joining the firm, Cheuk Hei interned in the New York University Office of Industrial Liaison/Technology Transfer. He conducted patentability assessments and strategized responses to Office actions for inventions that originated in New York University.

Education
  • Postdoctoral Research, New York University Langone Medical Center2011-2020
  • Ph.D., Molecular Genetics, University of Toronto, 2011
  • B.Sc., Biology, The Hong Kong University of Science and Technology, 2004
Admissions
  • U.S. Patent and Trademark Office
Credentials
Education
  • Postdoctoral Research, New York University Langone Medical Center2011-2020
  • Ph.D., Molecular Genetics, University of Toronto, 2011
  • B.Sc., Biology, The Hong Kong University of Science and Technology, 2004
Admissions
  • U.S. Patent and Trademark Office

Select Publications

  • Co-author, “Specific Isoforms of the Guanine-Nucleotide Exchange Factor dPix Couple Neuromuscular Synapse Growth to Muscle Growth,” 54(1) Developmental Cell 117-131, July 6, 2020
  • Co-author, “m6A modulates neuronal functions and sex determination in Drosophila,” 540(7632) Nature 242-247, December 8, 2016
  • Co-author, “Dosage suppression genetic interaction networks map: A functional wiring diagram of the cell,” 29(6) Nature Biotechnology 505-11, May 15, 2011
  • Co-author, “Combining Functional Genomics and Chemical Biology to Identify Targets of Bioactive Compounds,” 15(1) Current Opinion in Chemical Biology 66-78, February 2011
  • Co-author, “The Awesome Power of Synergy From Chemical-Chemical Profiling,” 17(8) Chemistry and Biology 789-90, August 27, 2010
  • Co-author, “A molecular barcoded yeast ORF library enables mode-of-action analysis of bioactive compounds,” 27(4) Nature Biotechnology 369-77, April 2009
  • Co-author, “Exploring the Mode-Of-Action of Bioactive Compounds by Chemical-Genetic Profiling in Yeast,” 126(3) Cell 611-25, August 11, 2006
Insights

Select Publications

  • Co-author, “Specific Isoforms of the Guanine-Nucleotide Exchange Factor dPix Couple Neuromuscular Synapse Growth to Muscle Growth,” 54(1) Developmental Cell 117-131, July 6, 2020
  • Co-author, “m6A modulates neuronal functions and sex determination in Drosophila,” 540(7632) Nature 242-247, December 8, 2016
  • Co-author, “Dosage suppression genetic interaction networks map: A functional wiring diagram of the cell,” 29(6) Nature Biotechnology 505-11, May 15, 2011
  • Co-author, “Combining Functional Genomics and Chemical Biology to Identify Targets of Bioactive Compounds,” 15(1) Current Opinion in Chemical Biology 66-78, February 2011
  • Co-author, “The Awesome Power of Synergy From Chemical-Chemical Profiling,” 17(8) Chemistry and Biology 789-90, August 27, 2010
  • Co-author, “A molecular barcoded yeast ORF library enables mode-of-action analysis of bioactive compounds,” 27(4) Nature Biotechnology 369-77, April 2009
  • Co-author, “Exploring the Mode-Of-Action of Bioactive Compounds by Chemical-Genetic Profiling in Yeast,” 126(3) Cell 611-25, August 11, 2006

Biological Sciences and Biotechnology

  • Cancer biology
  • Cell biology
  • Cell therapy
  • Cellular biology
  • Genetics
  • Genomics
  • Microbiology
  • MicroRNA (miRNA) research
  • Neurobiology
  • PCR
  • Virology

Therapeutics and Drug Discovery

  • CRISPR
  • Gene editing
  • Gene therapy
  • Peptide therapeutics

Diagnostics and Medical Devices

  • miRNA detection

Genomics and Data Analysis

  • Functional genomics
  • Next-generation sequencing
  • Sequencing
  • Single-cell sequencing

Miscellaneous

  • Food science
  • Infectious diseases
Technical Fluency

Biological Sciences and Biotechnology

  • Cancer biology
  • Cell biology
  • Cell therapy
  • Cellular biology
  • Genetics
  • Genomics
  • Microbiology
  • MicroRNA (miRNA) research
  • Neurobiology
  • PCR
  • Virology

Therapeutics and Drug Discovery

  • CRISPR
  • Gene editing
  • Gene therapy
  • Peptide therapeutics

Diagnostics and Medical Devices

  • miRNA detection

Genomics and Data Analysis

  • Functional genomics
  • Next-generation sequencing
  • Sequencing
  • Single-cell sequencing

Miscellaneous

  • Food science
  • Infectious diseases
Focus Areas
  • Intellectual Property
  • Life Sciences
  • Patents and Innovations
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.